B4. Oral Session: Tobacco Products and E-Cigarettes: Smoking Cessation Among Specific Populations in NYC and California
B4.02 - Oral: A Multilevel Integrated Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
Wednesday, April 16, 2025
1:45 PM – 2:00 PM PST
Location: Gallerie I, 1st Floor
Earn 1.0 Advanced CECH
Area of Responsibility: Area IV: Evaluation and Research Subcompetencies: 4.2.4 Assess capacity to conduct research., 4.2.5 Select a research design model and the types of data to be collected. Research or Practice: Research
Associate Professor LSUHSC New Orleans, Louisiana, United States
Learning Objectives:
At the end of this session, participants will be able to:
Explore and address the smoking cessation needs of at-risk African American smokers undergoing lung cancer screening.
Exam effectiveness of multiple-level intervention using the ideal teachable moment and content (barriers and facilitators) for a smoking cessation intervention in a lung cancer screening context.
Understand the tobacco and cancer related disparities.
Brief Abstract Summary: African Americans have both the highest incidence and mortality of lung cancer compared to any other racial/ethnic group. To address this urgent public health concern, this study aims to reduce disparities and the burden of lung cancer among AA smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation(MILS), following the NIH strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course. The results of the study will directly guide the development of targeted strategies to improve lung cancer screening rates among minorities.
Detailed abstract description: African Americans have both the highest incidence and mortality of lung cancer compared to any other racial/ethnic group. A possible explanation for this disparity is that African Americans (AA) may be less likely to utilize preventative screenings such as Low-dose computed tomography(LDCT), which has the potential to encourage smokers to quit smoking successfully. In 2021, the USPSTF expanded their lung cancer screening (LCS) recommendations to include individuals ages 50-80 years with at least a 20 pack-year history, increasing the number of eligible U.S. adults. While the expanded criteria are expected to increase the number of high-risk individuals eligible for screening and reduce lung cancer mortality, the impact on racial and ethnic minorities, including African Americans, has shown mixed findings. This is problematic as previous research has found that African Americans may have different quit behaviors than whites. While the use of LCS as a teachable moment for tobacco cessation is important, currently, there is no well-integrated, comprehensive, culturally relevant, community-engaged, sustainable program. Still, it is not clear whether the synergy effect of smoking cessation and LDCT LCS intervention was observed in both quitting behaviors and LDCT uptake among African-American smokers. To address this urgent public health concern, this study aims to reduce disparities and the burden of lung cancer among AA smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation(MILS), following the NIH strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course. To date, no study has evaluated the synergy effect of smoking cessation intervention and LDCT LCS in AA populations with multilevel strategies. We will move the field forward by providing effective, scalable interventions to improve both smoking cessation and LDCT lung cancer screening adherence to reduce health disparities promised by large clinical trials that motivated screening guidelines. The results of the study will directly guide the development of targeted strategies to improve lung cancer screening rates among minorities.
